Levaquin (levofloxacin) has been approved by the FDA for the treatment and prevention of the plague. Levofloxacin is a synthetic antibiotic of the fluoroquinolones drug class; it is currently used for the treatment of severe bacterial infection, or infections for which other antibiotics have not worked. Levaquin is produced and marketed by Janssen Pharmaceuticals Inc., a Johnson & Johnson company.
In a bid to stem the growing problem of antibiotic resistance in humans, the US Food and Drug Administration has announced it is taking steps to phase out non-medicinal use of antibiotics in animals used for food production.Many liv... Read Post
The U.S. Food and Drug Administration approved the first generic versions of Levaquin (levofloxacin), an antibiotic approved to treat certain infections in people ages 18 and older. Levofloxacin is used to treat mild, moderate, or s... Read Post